By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Heat Biologics 

Atlantic Center
119 Washington Avenue, Suite 401
Miami Beach  Florida  33139  U.S.A.
Phone: 305-432-4684 Fax: n/a



Company News
Heat Biologics Announces Financial Results For The Year Ended December 31, 2014 3/27/2015 6:56:14 AM
Heat Biologics Announces Closing Of Public Offering Of Common Stock And Full Exercise Of The Underwriters' Over-Allotment Option 3/17/2015 7:57:47 AM
Heat Biologics Announces Pricing Of Public Offering Of $10,660,000 Of Common Stock 3/11/2015 7:34:43 AM
Heat Biologics Announces Proposed Public Offering Of Common Stock 3/11/2015 7:33:46 AM
Heat Biologics Receives U.S. FDA Fast Track Designation For HS-410 (Vesigenurtacel L) In Combination With BCG For The Treatment Of Non-Muscle Invasive Bladder Cancer 3/9/2015 7:40:08 AM
Heat Biologics Provides Update At Key Opinion Leader Event 2/26/2015 1:31:24 PM
Heat Biologics To Host Key Opinion Leader Meeting On February 26 In New York City 2/23/2015 8:20:58 AM
Heat Biologics And OncoSec Medical Inc. Announce Collaboration To Evaluate Combination Of Immunotherapy Platforms 2/18/2015 8:27:44 AM
Heat Biologics Presents Positive Preclinical Data On A Novel Approach To Combination Immunotherapy At The Keystone Symposia On Tumor Immunology 2/11/2015 7:49:43 AM
Heat Biologics Outlines 2015 Corporate Objectives 2/2/2015 9:18:19 AM